Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,480Revenue (TTM) $M2,067Net Margin (%)4.8Altman Z-Score4.2
Enterprise Value $M5,104EPS (TTM) $3.3Operating Margin %6.6Piotroski F-Score5
P/E(ttm)55.7Beneish M-Score-2.4Pre-tax Margin (%)6.0Higher ROA y-yN
Price/Book2.010-y EBITDA Growth Rate %5.3Quick Ratio2.9Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %-7.9Current Ratio4.2Lower Leverage y-yY
Price/Free Cash Flow167y-y EBITDA Growth Rate %-2.5ROA % (ttm)2.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)3.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.5ROIC % (ttm)4.9Gross Margin Increase y-yN

Gurus Latest Trades with BIO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIOKen Fisher 2016-12-31 Reduce$155.52 - $183.46
($170.48)
$ 186.439%Reduce -2.34%283,625
BIONWQ Managers 2016-09-30 Reduce-0.08%$141.34 - $163.81
($151.78)
$ 186.4323%Reduce -6.53%470,577
BIOJohn Rogers 2016-09-30 Reduce-0.04%$141.34 - $163.81
($151.78)
$ 186.4323%Reduce -2.33%958,046
BIOMariko Gordon 2016-09-30 Reduce-0.01%$141.34 - $163.81
($151.78)
$ 186.4323%Reduce -5.76%19,217
BIOMario Gabelli 2016-09-30 Reduce$141.34 - $163.81
($151.78)
$ 186.4323%Reduce -3.30%61,112
BIOKen Fisher 2016-09-30 Add$141.34 - $163.81
($151.78)
$ 186.4323%Add 3.14%290,416
BIONWQ Managers 2016-06-30 Add0.2%$135.03 - $149.99
($142.54)
$ 186.4331%Add 19.15%503,466
BIOMariko Gordon 2016-06-30 Buy 0.19%$135.03 - $149.99
($142.54)
$ 186.4331%New holding20,392
BIOJoel Greenblatt 2016-06-30 Sold Out -0.1%$135.03 - $149.99
($142.54)
$ 186.4331%Sold Out0
BIOJohn Rogers 2016-06-30 Reduce-0.04%$135.03 - $149.99
($142.54)
$ 186.4331%Reduce -2.35%980,851
BIOKen Fisher 2016-06-30 Add$135.03 - $149.99
($142.54)
$ 186.4331%Add 4.65%281,583
BIOMario Gabelli 2016-06-30 Reduce$135.03 - $149.99
($142.54)
$ 186.4331%Reduce -4.96%63,200
BIOPrivate Capital 2016-03-31 Sold Out -0.25%$123.93 - $138.97
($131.21)
$ 186.4342%Sold Out0
BIOJoel Greenblatt 2016-03-31 Reduce-0.04%$123.93 - $138.97
($131.21)
$ 186.4342%Reduce -25.83%67,705
BIONWQ Managers 2016-03-31 Reduce-0.01%$123.93 - $138.97
($131.21)
$ 186.4342%Reduce -0.78%422,546
BIOKen Fisher 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 186.4342%Reduce -2.02%269,075
BIOMario Gabelli 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 186.4342%Reduce -0.75%66,500
BIOJohn Rogers 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 186.4342%Reduce -0.14%1,004,492
BIONWQ Managers 2015-12-31 Reduce-0.04%$134.34 - $141.7
($138.69)
$ 186.4334%Reduce -4.00%425,876
BIOJoel Greenblatt 2015-12-31 Reduce-0.03%$134.34 - $141.7
($138.69)
$ 186.4334%Reduce -21.15%91,287
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STARK JAMES RVP, Corporate Controller 2016-11-09Sell1,299$171.429.34view
STARK JAMES RVP, Corporate Controller 2016-11-07Sell76$165.6213.17view
Magni GiovanniEVP, Chief Strategy Officer 2016-11-07Sell91$165.6213.17view
HERTIA JOHNExecutive Vice President 2016-11-07Sell227$165.6213.17view
Crowley MichaelEVP, GBL Commercial Operations 2016-11-07Sell88$165.6213.17view
Hall ShannonExecutive Vice President 2016-11-07Sell84$165.6213.17view
STARK JAMES RVP, Corporate Controller 2016-09-13Sell76$158.0918.56view
Magni GiovanniEVP, Chief Strategy Officer 2016-09-13Sell92$158.0718.57view
HERTIA JOHNExecutive Vice President 2016-09-13Sell228$158.0818.57view
Hall ShannonExecutive Vice President 2016-09-13Sell92$158.0818.57view

Press Releases about BIO :

Quarterly/Annual Reports about BIO:

News about BIO:

Articles On GuruFocus.com
Mariko Gordon Invested in 5 Companies in 2nd Quarter Aug 21 2016 
Royce 100 Fund Shareholder Letter Sep 20 2015 
Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/B May 12 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 23 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 14 2014 

More From Other Websites
Bio-Rad to Report Fourth-Quarter and Full-Year 2016 Financial Results Thursday, February 23, 2017 Jan 18 2017
Coverage initiated on Bio-Rad Labs by Deutsche Bank Jan 18 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bio-Rad... Jan 18 2017
[$$] Bio-Rad to Acquire Former IPO Aspirant RainDance Jan 17 2017
[$$] Trial Reveals Pitfalls of Whistleblower Claims From In-House Corporate Lawyers Jan 17 2017
Bio-Rad to Acquire RainDance Technologies and Droplet Intellectual Property Jan 16 2017
[$$] Trial Reveals Pitfalls of Whistleblower Claims From In-House Lawyers Jan 15 2017
Illumina and Bio-Rad Unveil Single-Cell Sequencing Solution Jan 12 2017
Stocks Mixed; Why Are Illumina, Valeant, Barracuda Soaring? Jan 10 2017
Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of... Jan 09 2017
ETFs with exposure to Bio-Rad Laboratories, Inc. : January 9, 2017 Jan 09 2017
BIO RAD LABORATORIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 27 2016
ETFs with exposure to Bio-Rad Laboratories, Inc. : December 9, 2016 Dec 09 2016
Hedge Funds Are Betting On Bio-Rad Laboratories, Inc. (BIO) Dec 01 2016
Microbiome MDx specialist Genetic Analysis and Bio-Rad Sign Agreement Nov 28 2016
Microbiome MDx specialist Genetic Analysis and Bio-Rad Sign Agreement Nov 28 2016
ETFs with exposure to Bio-Rad Laboratories, Inc. : November 16, 2016 Nov 16 2016
BIO RAD LABORATORIES INC Financials Nov 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)